Verastem, Inc. Reports Third Quarter 2013 Financial And Corporate Results
Published: Nov 12, 2013
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today reported financial results for the third quarter ended September 30, 2013, and also provided an overview of certain corporate accomplishments and plans.
Help employers find you! Check out all the jobs and post your resume.